EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis

JuanJuan Yin iD, Asha Daryanani, Fan Lu, Anson T Ku, John R Bright, Aian Neil S Alilin, Joel Bowman, Ross Lake, Chennan Li, Tri M Truong, Joseph D Twohig, Elahe A Mostaghel und 6 weitere

The Prostate · 2024

DOI: 10.1002/pros.24718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von JuanJuan Yin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Bone Neoplasms, Prostatic Neoplasms, Receptors, Androgen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS, NCI NIH HHS, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preclinical models recapitulating the metastatic phenotypes are essential for developing the next‐generation therapies for metastatic prostate cancer (mPC). We aimed to establish a cohort of clinically relevant mPC models, particularly androgen receptor positive (AR + ) bone metastasis models, from LuCaP patient‐derived xenografts (PDX) that reflect the heterogeneity and complexity of mPC.

Methods

PDX tumors were dissociated into single cells, modified to express luciferase, and were inoculated into NSG mice via intracardiac injection. The progression of metastases was monitored by bioluminescent imaging. Histological phenotypes of metastases were characterized by immunohistochemistry and immunofluorescence staining. Castration responses were further investigated in two AR‐positive models.

Results

Our PDX‐derived metastasis (PDM) model collection comprises three AR + adenocarcinomas (ARPC) and one AR − neuroendocrine carcinoma (NEPC). All ARPC models developed bone metastases with either an osteoblastic, osteolytic, or mixed phenotype, while the NEPC model mainly developed brain metastasis. Different mechanisms of castration resistance were observed in two AR + PDM models with distinct genotypes, such as combined loss of TP53 and RB1 in one model and expression of AR splice variant 7 (AR‐V7) expression in another model. Intriguingly, the castration‐resistant tumors displayed inter‐ and intra‐tumor as well as organ‐specific heterogeneity in lineage specification.

Conclusion

Genetically diverse PDM models provide a clinically relevant system for biomarker identification and personalized medicine in metastatic castration‐resistant prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsProstatic NeoplasmsReceptors, AndrogenAnimalsHumansMaleMiceAdenocarcinomaCarcinoma, NeuroendocrineDisease Models, AnimalProstatic Neoplasms, Castration-Resistant

Stichwörter der Autor:innen

PDXbone metastasiscastration resistancemetastasis modelprostate cancer

Substanzen

AR protein, humanReceptors, Androgen

Autor:innen und Institutionen

  • Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, Maryland, USA.
  • Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Department of Pharmacology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
  • Department of Medicine, University of Washington, Seattle, Washington, USA.

ORCID-Profile: JuanJuan Yin, Adam G Sowalsky

Förderung

  • Intramural NIH HHS
  • NCI NIH HHS
  • Congressionally Directed Medical Research Programs

Zitieren

APA

Yin, J., Daryanani, A., Lu, F., Ku, A. T., Bright, J. R., Alilin, A. N. S., Bowman, J., Lake, R., Li, C., Truong, T. M., Twohig, J. D., Mostaghel, E. A., Ishikawa, M., Simpson, M., Trostel, S. Y., Corey, E., Sowalsky, A. G., & Kelly, K. (2024). Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis. The Prostate. https://doi.org/10.1002/pros.24718

Vancouver

Yin J, Daryanani A, Lu F, Ku AT, Bright JR, Alilin ANS, et al. Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis. The Prostate. 2024. doi:10.1002/pros.24718

BibTeX
@article{Yin2024,
  author = {Yin, JuanJuan and Daryanani, Asha and Lu, Fan and Ku, Anson T and Bright, John R and Alilin, Aian Neil S and Bowman, Joel and Lake, Ross and Li, Chennan and Truong, Tri M and Twohig, Joseph D and Mostaghel, Elahe A and Ishikawa, Masaki and Simpson, Mark and Trostel, Shana Y and Corey, Eva and Sowalsky, Adam G and Kelly, Kathleen},
  title = {Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24718}
}
Kostenlos starten →